2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: TPK1 mutation induced childhood onset dystonia and dyskinesia

L. Au, A. Chan, C. Lau, V. Mok (Hong Kong, Hong Kong)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Transcranial Direct Current Stimolation (tDCS) on PD Patients with Freezing of Gait: Preliminary Findings

S. Scalise, G. Di Lazzaro, M. Alwardat, NB. Mercuri, M. Patera, G. Saggio, T. Schirinzi, A. Pisani (Rome, Italy)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Transcranial sonography in carriers of Gaucher disease

F. Omrani, N. Mohammadzade, M. Rohani, Z. Omrani, B. Zamani (Tehran, Islamic Republic of Iran)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3

1:45pm-3:15pm: Translating Preclinical Data to a Human Equivalent Dose for AMT-130 AAV Gene Therapy for Early Manifest Huntington’s Disease

M. Evers, M. de Haan, A. Valles-Sanchez, E. Sawyer, S. Gill, R. Roos, S. van Deventer, P. Konstantinova, J. Higgins (Amsterdam, Netherlands)

Huntington’s Disease · Agora 3 West, Level 3

1:45pm-3:15pm: Treating Depression in Parkinson’s Disease: a Systematic Literature Review

C. Farrell, T. Yousaf, M. Politis (London, United Kingdom)

Psychiatric Manifestations · Les Muses Terrace, Level 3

1:45pm-3:15pm: Treatment monitoring using objective and frequent digital testing in the D1PAM (LY3154207) phase 1B Parkinson’s disease clinical trial

J. Wang, C. Battioui, Y. Li, A. Calvin, L. Wu, A. Romano, B. Miller (Indianapolis, IN, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Treatment of dopaminergic augmented RLS with Ecopipam, A D1 specific antagonist: an exploratory placebo controlled cross-over trial

O. Titlayo, W. Ondo (Houston, TX, USA)

Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: Treatment of subcutaneous nodules after subcutaneous infusion of apomorphine

RWK. Borgemeester, GFH. Diercks, T. van Laar (Groningen, Netherlands)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Tremor and parkinsonism in Chromosomopathies – a systematic review

V. Carvalho, L. Guedes (Matosinhos, Portugal)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Trends in first line therapy for PD in Wales: A 16 year observational study

K. Orayj, A. Lacey, A. Akbari, O. Pickrell, E. Lane (Cardiff, United Kingdom)

Other · Agora 2 West, Level 2